BOXER CAPITAL, LLC
Filing Date
Global Rank
#1,187
/ 7,310
▲ 40
· as of Sep 2024
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+9.1%
Period ended 1 year ago
Filed Nov 14, 2024 · 1y
19 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+102.6%
SPY
+76.5%
Annualised alpha
+5.7%
Max drawdown
−56.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
57 positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Top Position
11.5%
+0.4 pts
Top 5
40.6%
+2.5 pts
Top 10
60.1%
−0.2 pts
HHI
477
Diversified+12
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,683,915,519 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | +250,000 | 907,895 | $15,198,162 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | −3,255,000 | 4,960,910 | $17,363,185 | |
| NKTX | Nkarta, Inc. | −1,577,744 | 4,029,606 | $18,213,819 | |
| IPSC | Century Therapeutics, Inc. | −1,001,603 | 3,900,000 | $6,669,000 | |
| PRLD | Prelude Therapeutics Inc | −860,100 | 1,708,187 | $3,535,947 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TIL | Instil Bio, Inc. | 355,500 | $23,932,260 | |
| KYMR | Kymera Therapeutics, Inc. | 450,000 | $21,298,500 | |
| NRIX | Nurix Therapeutics, Inc. | 563,067 | $12,652,115 | |
| QURE | uniQure N.V. | 2,225,000 | $10,969,250 | |
| APGE | Apogee Therapeutics, Inc. | 179,000 | $10,514,460 | |
| TERN | Terns Pharmaceuticals, Inc. | 752,000 | $6,271,680 | |
| SRRK | Scholar Rock Holding Corp | 750,000 | $6,007,500 | |
| SMMT | Summit Therapeutics Inc. | 250,000 | $5,475,000 | |
| BCAX | Bicara Therapeutics Inc. | 135,000 | $3,438,450 | |
| ZURA | Zura Bio Ltd | 300,000 | $1,218,000 | |
| No positions match the current search. | ||||
57 positions ·
$1,683,915,519 total
· as of Sep 30, 2024
Showing 1–50
of 57 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 4,279,464 | $194,073,692 | 11.53% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 6,448,359 | $151,600,920 | 9.00% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Held | 1,120,192 | $114,595,641 | 6.81% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Held | 500,000 | $112,255,000 | 6.67% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 2,100,000 | $110,880,000 | 6.58% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 650,000 | $81,178,500 | 4.82% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 2,202,812 | $69,785,084 | 4.14% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 8,198,642 | $63,129,543 | 3.75% | |
| BCAB |
BioAtla, Inc.
Healthcare
|
Held | 686,347 | $60,398,536 | 3.59% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 100,000 | $54,208,000 | 3.22% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Held | 1,726,000 | $49,777,840 | 2.96% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Held | 400,000 | $35,948,000 | 2.13% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 600,000 | $29,238,000 | 1.74% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Held | 1,300,000 | $29,033,290 | 1.72% | |
| GERN |
Geron Corp
Healthcare
|
Held | 6,000,000 | $27,240,000 | 1.62% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 1,466,051 | $27,077,961 | 1.61% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 1,602,200 | $24,497,638 | 1.45% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
NEW | 355,500 | $23,932,260 | 1.42% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 600,000 | $23,622,000 | 1.40% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Held | 825,000 | $23,520,750 | 1.40% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
NEW | 450,000 | $21,298,500 | 1.26% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 696,480 | $20,483,476 | 1.22% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 1,000,000 | $19,540,000 | 1.16% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Held | 1,590,000 | $18,412,200 | 1.09% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Reduced | 4,029,606 | $18,213,819 | 1.08% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 1,732,571 | $17,758,852 | 1.05% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Held | 400,000 | $17,556,000 | 1.04% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Reduced | 4,960,910 | $17,363,185 | 1.03% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Held | 671,358 | $17,146,483 | 1.02% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Held | 1,536,341 | $16,838,297 | 1.00% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
Held | 1,189,943 | $16,575,905 | 0.98% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Added | 907,895 | $15,198,162 | 0.90% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Held | 608,614 | $14,990,162 | 0.89% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Held | 2,603,190 | $13,250,237 | 0.79% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 1,819,132 | $12,879,454 | 0.76% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 563,067 | $12,652,115 | 0.75% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Held | 690,000 | $11,543,700 | 0.69% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 2,225,000 | $10,969,250 | 0.65% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 179,000 | $10,514,460 | 0.62% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 650,000 | $7,761,000 | 0.46% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Held | 750,000 | $7,042,500 | 0.42% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Reduced | 3,900,000 | $6,669,000 | 0.40% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 350,000 | $6,583,500 | 0.39% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
Held | 1,545,000 | $6,427,200 | 0.38% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
NEW | 752,000 | $6,271,680 | 0.37% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
NEW | 750,000 | $6,007,500 | 0.36% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 250,000 | $5,475,000 | 0.33% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 727,900 | $4,804,140 | 0.29% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
Reduced | 1,708,187 | $3,535,947 | 0.21% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
NEW | 135,000 | $3,438,450 | 0.20% |